BRADLEY PHARMACEUTICALS INC 4
4 · BRADLEY PHARMACEUTICALS INC · Filed Mar 22, 2007
Insider Transaction Report
Form 4
BRADLEY PHARMACEUTICALS INCNYSE: BDY
GLASSMAN BRADLEY
Senior VP - Sales & Marketing
Transactions
- Exercise/Conversion
Common Stock
2007-03-21$7.05/sh+30,000$211,500→ 74,494 total - Exercise/Conversion
Stock Options (Right to buy)
2007-03-21$7.05/sh−30,000$211,500→ 30,000 totalExercise: $7.05From: 2002-07-09Exp: 2011-07-08→ Common Stock (30,000 underlying)
Holdings
- 16,349(indirect: By 401(k))
Common Stock
- 3,359(indirect: By 401(k))
Common Stock
- 15,620(indirect: By Trust)
Common Stock
- 20,880(indirect: By Trust)
Class B Common Stock
- 100,000
Stock Options (Right to buy)
Exercise: $13.41From: 2006-11-22Exp: 2015-11-21→ Common Stock (100,000 underlying)